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Background/aim: The present study investigated the neuroprotective effects of chrysin (CRS) following global cerebral ischemia and
reperfusion (I/R) in a C57BL/J6 mouse model.
Materials and methods: A total of 40 mice were equally divided into four groups: (1) sham-operated (SH = control), (2) global cerebral
I/R (I/R), (3) CRS, and (4) CRS + I/R. In the I/R group, the bilateral carotid arteries were clipped for 15 min and the mice were treated
with vehicle (corn oil) for 10 days. In the CRS group, CRS (50 mg/kg) was given for 10 days without carotid occlusion. In the CRS + I/R
group bilateral carotid arteries were clipped for 15 min and the mice were also treated with CRS (50 mg/kg) for 10 days. All of the rats
were sacrificed under anesthesia on day 10, and neurodegenerative histological changes in the brain and tissue levels of oxidants and
antioxidants were evaluated.
Results: CRS treatment significantly reversed the oxidative effects of I/R and inhibited the development of neurodegenerative
histopathologies. In the CRS + I/R group, the decrease in TBARS levels and increase in GSH levels were similar to those in the SH group.
Conclusion: Treatment with CRS can positively affect the neural system of mice and it can be used for the treatment of global cerebral
I/R.
Key words: Chrysin, neuroprotection, global ischemia/reperfusion, C57 BL /J6 mice

1. Introduction
Cerebral stroke is the second most common cause of death
and disability in the world (1). Nearly half of all surviving
stroke patients experience insufficient recovery, and half
of these patients require assistance during activities of
daily life (2). Approximately 70% of strokes are ischemic.
Cerebral ischemic stroke typically originates from an
initial interruption of blood flow, but even during the
subsequent restoration of blood supply there may be
insufficient delivery of oxygen and glucose to support
cellular homeostasis (3,4). The interruption of blood flow
leads to neuronal damage via the oxidation of intracellular
molecules such as lipids, proteins, and DNA (5). It is well
known that oxidative stress caused by the activation of
reactive oxygen species (ROS) is a critical pathological
component of cerebral ischemic injury. Thus, antioxidant
agents that possess the ability to scavenge ROS have the
* Correspondence: makifdurak@yahoo.com
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potential to mitigate the neurological damage caused
by ischemia/reperfusion (I/R) (6,7). In the study by Yen
et al., I/R injury has been shown with the occurrence of
free oxygen radicals in the brain and causes the onset of
programmed cell death (8). According to this pathological
process, antioxidant agents could diminish the neurological
damage caused by I/R.
Natural flavonoids and derivatives have been shown
with several biological activities and a lot of beneficial
properties, such as antioxidant, anti-inflammatory,
antitumor, anti-allergic, neuroprotective, cardioprotective,
and antimicrobial (9). The antioxidant properties of
flavonoids allow them to display potential application as
preventive and attenuating agents in oxidative stress (9).
CRS (5,7 dihydroxyflavone) is a natural flavonoid that is
present in honey, bee propolis, and many plant extracts
(6,7). CRS has a broad range of pharmacological capabilities
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including anticancer, antioxidant, and antiinflammatory
activities (10–12). It was shown that propolis and its most
abundant component CRS have especially antioxidant
effects and significantly decrease lipid peroxidation in the
plasma, liver, lungs, and brain of mice (13).
We supposed that CRS, with its antiinflammatory and
antioxidant properties, might exert a beneficial effect on
ischemic brain tissue. The primary aim of the present
study was to assess the possible neuroprotective effects of
CRS in a mouse model of global I/R.
2. Materials and methods
2.1. Animals and experimental protocol
The present study was approved by the Ethics Committee
on Animal Research of İnönü University and carried out in
accordance with the Guidelines for Animal Research from
the National Institutes of Health (NIH). C57BL/6J male
mice (clean grade) weighing 18–22 g were supplied by the
İnönü University Laboratory Animals Research Center
(Malatya, Turkey), housed in sterilized polypropylene
cages, and given an ad libitum diet of standard commercial
food pellets and water. All mice were kept under a 12:12
h light:dark cycle at 21 ± 2 °C ambient temperature and
60 ± 5% humidity. A total of 40 animals (8 weeks old)
were randomly divided into four groups (n = 10): (1)
sham-operated (SH), (2) global cerebral I/R, (3) CRS, and
(4) CRS + global cerebral I/R (CRS + I/R). CRS (50 mg/
kg) was dissolved in corn oil and administered by gavage
(p.o.) for 10 consecutive days; the dose of CRS was based
on preliminary dose-finding experiments from our lab,
and the treatment was initiated concomitantly with the
induction of global cerebral I/R. Mice in the SH and I/R
groups were treated with only corn oil as a vehicle. In the
CRS and CRS + I/R groups, the mice were treated with CRS
(50 mg/kg/day) for 10 days following the I/R procedure.
At the end of the experimental period, all animals were
sacrificed under anesthesia, and tissue samples were
obtained for laboratory analyses.
2.2. Surgical procedure
To induce global cerebral ischemia, the mice were first
anesthetized with xylazine (5 mg/kg, i.p.) and ketamine
(100 mg/kg, i.p.), and the ischemic procedure was
performed according to the methods of Yonekura et al.
Briefly, after a midline cervical incision, the bilateral
common carotid arteries of the mice in the I/R and CRS
+ I/R groups were isolated and simultaneously occluded
for 15 min using two vascular mini clips (14). The same
surgical procedure was applied to the SH and CRS groups
except that the carotid arteries were not clipped. Following
surgery, all mice were placed in a thermal room until they
recovered from anesthesia.

2.3. Biochemical analyses
The tissue homogenization process has been briefly
described in a previous study from our lab. Additionally,
this study describes the spectrophotometric methods used
to determine the levels of TBARS and total GSH and the
activities of catalase (CAT) and superoxide dismutase
(SOD) and glutathione peroxidase (GPx) (15,16).
2.4. Histological evaluation
To prepare for evaluation with a light microscope, the brain
tissue samples were fixed in 10% formalin and embedded
in paraffin. The paraffin-embedded specimens were cut
into 5-µm-thick sections, mounted on slides, and stained
with hematoxylin–eosin (H-E). All tissue samples were
examined using a Leica DFC280 light microscope and a
Leica Q Win Image Analysis system (Leica Micros Imaging
Solutions, Ltd., Cambridge, UK). For the evaluations,
cerebral and cerebellum damage was semiquantitatively
graded as 0 normal, 1 mild, 2 moderate, 3 severe, for
each criterion. Additionally the thickness of total cerebral
cortex and cerebellum cortex layers (molecular, Purkinje
cell, and granular layers) from ten different areas of each
specimen was measured.
For the immunohistochemical analyses, 5-µm-thick
tissue sections were mounted on polylysine-coated slides.
Following rehydration, the sections were transferred to
a citrate buffer (pH 7.6), heated in a microwave oven for
20 min, and then cooled for 20 min at room temperature.
The sections were then washed with phosphate-buffered
saline (PBS), placed in 0.3% H2O2 for 7 min, and washed
again with PBS. Next, the sections were incubated with
primary rabbit-polyclonal caspase-3 antibody (Abcam,
Ab4051) for 2 h, rinsed in PBS, incubated with biotinylated
goat antipolyvalent for 10 min, and then incubated in
streptavidin peroxidase for 10 min at room temperature.
The staining procedure was completed with a chromogen
+ substrate procedure for 15 min, and then the slides
were counterstained with Mayer’s hematoxylin for 1 min,
rinsed in tap water, and dehydrated. The caspase-3 kit was
used according to the manufacturer’s instructions. The
presence of cells undergoing apoptosis was determined
by the immunohistochemical detection of caspase-3. The
caspase-3-labeled cells (pyramidal neurons in the cerebral
cortex and Purkinje cells) were counted. Ten randomly
selected areas for each specimen were examined under a
40× objective.
2.5. Statistical analyses
SPSS 13.0 software (SPSS, Inc., Chicago, IL, USA) was used
for all statistical analyses. The biochemical values were
analyzed with one-way analysis of variance (ANOVA)
and a post hoc Tukey’s honestly significant differences
test. P-values ≤ 0.05 were considered to indicate statistical
significance.
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3. Results
3.1. Biochemical results
The values of the biochemical parameters (TBARS, GSH,
CAT, GPx, and SOD) in the brain tissues of the mice are
provided in the Table. In the global cerebral I/R group, there
was a significant increase in TBARS levels (P = 0.004) and
a significant decrease in GSH, CAT, GPx, and SOD levels
compared with the other groups (P = 0.005). However,
the CRS + I/R group showed a decrease in TBARS levels
and increase in GSH levels and an enhancement of the
diminished GSH levels to values similar to those of the SH
group. The CRS + I/R group also showed an increase in
CAT and SOD activities compared with the I/R group (P
= 0.014). Only GPx activity was not significantly affected
by CRS treatment relative to the I/R group, and these levels
did not return to normal values. However, the activities of
CAT and SOD were partially restored to normal values,
and there was a significant difference between the SH and
CRS + I/R groups (P = 0.005).
3.2. Histopathological results
In the SH (control) and CRS groups, the neurons in the
cortical brain tissue samples were observed as regular
and neurons were also intact with a normal histological
appearance and, in the I/R group, there were severe
degenerative changes in the neurons. CRS treatment
significantly ameliorated these harmful effects in the I/R
+ CRS group (Figures 1A–1D and 2A–2D). However,
the I/R group exhibited histological alterations including
shrinkage of the cytoplasm and extensively dark pyknotic
nuclei in the neurons of the cerebral cortex, cell infiltration,
vascular congestion as another remarkable finding in the
pia mater, hemorrhage, and vascular congestion (Figure 3).
In the SH (control) and CRS groups, the Purkinje cell layer
and granular layer were marked in the cerebellar cortex,
exhibiting a normal histological appearance with no
histological changes (Figures 4A and 4B). In the I/R group,
there were deeply stained, shrunken, and variously shaped
Purkinje cells with pyknotic nuclei; the Purkinje cell layer
was separated from the granular layer in this group, but

treatment with CRS in the I/R + CRS group decreased the
number of degenerative Purkinje cells (Figures 4C and
4D). In the I/R group, the cerebral and cerebellum cortex
were thinner than in the SH and CRS groups (P = 0.001).
No significant difference was found between the CRS and
I/R + CRS groups in terms of neuronal appearance (P >
0.05).
Immunohistochemically caspase-3–stained cells were
not observed except for a few cells in the cerebral cortex in
the SH or CRS group, but there was a high percentage of
caspase-3–positive cells in the I/R group (Figures 5A–5C).
However, evaluations of caspase-3 immunohistochemistry
revealed a large number of apoptotic neurons after I/R
exposure in the cerebrum and cerebellum. The density
of immunohistochemically caspase -3-stained cells was
minimal in the I/R + CRS group (Figure 5D).
4. Discussion
The main finding of this study was that CRS attenuates
the neuronal damage caused by global cerebral I/R. The
quick recanalization of occluded cerebral arteries is a
radical treatment for strokes caused by ischemia and
may be applied as a primary treatment procedure (17).
However, after cerebral ischemia and cerebral edema,
reperfusion via vessel recanalization can result in brain
damage that will lead to complications such as cerebral
hemorrhage and/or the death of neurons, even if done
correctly; this phenomenon is known as cerebral I/R
injury (18). ROS and oxidative stress play key roles in
the pathogenesis of I/R injury because they are released
during reperfusion following cerebral ischemia and can
initiate a chain reaction that leads to the activation of cell
death signaling pathways in mitochondria. Therefore,
this increase in free radicals may be accompanied by
fatal brain damage following ischemia. There has been a
recent increase in the occurrences of free radicals and lipid
peroxidation after ischemic attacks, which suggests that it
is of increasing importance to develop compounds with
radical scavenging capabilities to treat I/R injuries (19–
21). In recent years, the importance of a radical scavenging

Table. Levels of SOD, CAT, GPx, GSH, and TBARS in the brain tissue of C57 BL/J6 mice.
(Mean ± SD)

TBARS nmol/g
tissue

Reduced GSH
nmol/mL

CAT k/mg
protein

SOD U/mg
protein

GPx U/mg
protein

Sham

8.51 ± 1.09a

190.1 ± 4.7a

0.031 ± 0.0010a

29.12 ± 1.98a

205.8 ± 16.3a

I/R

14.3 ± 1.21b

135.8 ± 5.1b

0.021 ± 0.0009b

16.61 ± 1.19b

158.5 ± 14.9b

CRS

8.83 ± 1.17a

201.4 ± 4.9a

0.032 ± 0.0012a

28.52 ± 1.96a

216.2 ± 17.1a

I/R + CRS

9.3 ± 0.96a

165.8 ± 7.1c

0.026 ± 0.0007c

23.49 ± 2.18c

169.1 ± 12.4b

Means bearing different superscripts within the same column are significantly different (P < 0.01).
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Figure 1. In the SH (control) (A) and CRS (B, D) groups, the neurons in the cortical brain tissue samples were observed as regular and
neurons were also intact with a normal histological appearance. In the I/R group (C), there were severe degenerative changes in the
neurons. Sections of cerebral cortical tissue from all groups. H-E, 20×.

Figure 2. In the control (A) and CRS (B) groups, the cerebral cortical neurons exhibited a normal histological appearance. In the I/R
group (C), there were severe degenerative changes in the neurons, but there was a decrease in the number of degenerative neurons in
the I/R + CRS group (D) compared with the I/R group. H-E, 40×.
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Figure 3. In the I/R group, cell infiltration (A, B, E, F), vascular congestion (C, F), and hemorrhaging (D) were observed in the brain
tissue. A: H-E, 10×; B: H-E, 20×; C, D, F: H-E, 40×.

1930

DURAK et al. / Turk J Med Sci

Figure 4. In the control (A) and CRS (B) groups, the Purkinje cells exhibited a normal histological appearance, but in the I/R group
(C), the degenerative Purkinje cells were prominent. The number of degenerative Purkinje cells significantly decreased in the I/R + CRS
group (D). H-E, 40×.

Figure 5. Immunohistochemical caspase -3 staining in all experimental groups. There were no positively stained cells in the control (A)
or CRS (B) groups. There was a decrease in the percentage of positively stained cells in the I/R + CRS group (D) compared with the IR
group (C).
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compound experimental I/R treatment was found by
chance (11,18,22).
Flavonoids and flavones that naturally occur in honey,
vegetables, and fruits are also present in some plant-based
polyphenolic beverage compounds, and the antioxidant
properties of these compounds may be effective for the
treatment of many diseases (23,24). CRS is a natural
flavone obtained from many types of plant, honey, and
propolis (25,26). In fact, a number of recent studies have
shown that CRS is an antiinflammatory and a vasodilator
and has strong antioxidant effects (10,13,27).
In the present study, the efficacy of CRS for the
amelioration of the neuronal damage caused by global
cerebral I/R was examined in a C57/BL6 mouse
model. Treatment with CRS (50 mg/kg) protected the
central nervous system against I/R induced damage via
significant reductions in lipid peroxidation and significant
enhancements of enzymatic and nonenzymatic antioxidant
defense systems. Following global cerebral I/R in the
brains of mice, oxidative stress is a primary pathological
consequence that causes irreversible injury to neurons due
to enhanced lipid peroxidation via the action of ROS (28). In
the present study, this is evidenced by the elevation in TBARS
levels following the ischemic procedure. Furthermore, ROS
are produced in excess following the reperfusion process
and can cause downregulation in specific elements of the
antioxidant defense systems, including SOD, CAT, GPx,
and GSH (28). The oxidative stress that results from an
imbalance between TBARS levels and antioxidant defense
systems can be induced by the I/R process and may play
an important role in ischemic stroke injury (15,16). In
the present study, the I/R induced lipid peroxidation that
resulted from the significant increase in TBARS levels led to
irreversible neuronal damage. Additionally, the enzymatic
(SOD, CAT) and nonenzymatic (GSH) antioxidant defense
systems were suppressed in ischemic mice, and significant
decreases in SOD and CAT activities and the level of GSH,
a specific ROS scavenger, were observed. The signaling
pathways underlying I/R remain largely unknown, but
oxidative stress plays an important role in global cerebral
I/R. It is thought that oxidative stress causes significant
cell death and neuronal damage because the brain has a

large amount of oxidizable unsaturated fatty acids and low
antioxidant enzyme activity (28). The activities of CAT and
SOD were partially restored to normal values, and there was
a significant difference in these values between the SH and
CRS + I/R groups. In the CRS + I/R group, a decrease in
TBARS levels and an increase in GSH levels similar to those
in the SH group were identified. Thus, the present findings
demonstrate that CRS treatment effectively prevents
oxidative and histological damage in the brain following
global I/R.
The histopathological and immunohistopathological
findings of the present study revealed that I/R caused major
structural changes in brain tissue compared with the SH
animals. The primary damage included diffuse and focal
ischemic areas in the cerebral cortex as well as secondary
issues such as cell infiltration, vascular congestion,
shrinkage of the cytoplasm, and extensively dark pyknotic
nuclei in the neurons of cerebral cortical tissue. However,
in the present study, CRS treatment partially ameliorated
the histological changes caused by I/R and resulted in
significantly higher numbers of caspase-3–stained cells,
which are indicative of the apoptotic rate in neurons, in
the I/R group compared with the CRS + I/R group. Thus,
it is proposed here that CRS may protect against ischemic
damage via the attenuation of enhanced oxidative stress
activity and the prevention of histological damage in brain
tissue.
The present study demonstrated that 15 min of cerebral
I/R in C57BL/J6 mice resulted in neurodegenerative effects
that were associated with increases in oxidative stress and
histopathological changes in brain tissue. Additionally,
treatment with CRS (50 mg/kg per day) for 10 consecutive
days following cerebral I/R generally reversed the
potentially negative effects of I/R on brain tissue, likely due
to its strong antioxidant and radical scavenging properties.
Therefore, based on the present results, it is proposed that
CRS attenuates the neuronal damage caused by global
cerebral I/R.
Acknowledgment
We acknowledge the support of IUBAP (Scientific Research
Fund of İnönü University) under Grant 2013/204.

References
1.

Zhou XQ, Zeng XN, Kong H, Sun XL. Neuroprotective effects of
berberine on stroke models in vitro and in vivo. Neuroscience
Letters 2008; 447: 31-36.

2.

Bonita R, Solomon N, Broad JB. Prevalence of stroke and
stroke-related disability. Estimates from the Auckland stroke
studies. Stroke 1997; 28: 1898-1902.

1932

3.

Silvestrelli G, Corea F, Paciaroni M, Milia P, Palmerini F,
Parnetti L, Gallai V. The Perugia hospital-based stroke registry:
report of the 2nd year. Clinical and Experimental Hypertension
2002; 24: 485-491.

4.

Zhang S, Qi Y, Xu Y, Han X, Peng J, Liu K, Sun CK. Protective
effect of flavonoid-rich extract from Rosa laevigata Michx on
cerebral ischemia-reperfusion injury through suppression of
apoptosis and inflammation. Neurochem Int 2013; 63: 522532.

DURAK et al. / Turk J Med Sci
5.

Oztanir MN, Ciftci O, Cetin A, Durak MA, Basak N, Akyuva
Y. The beneficial effects of 18b-glycyrrhetinic acid following
oxidative and neuronal damage in brain tissue caused by global
cerebral ischemia/reperfusion in a C57BL/J6 mouse model.
Neurol Sci 2014; 35: 1221-1228.

17.

Hacke W, Donnan G, Fieschi, Kaste M, von Kummer R,
Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, et al.
Association of outcome with early stroke treatment: pooled
analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.
Lancet 2004; 363: 768-774.

6.

Heo JH, Han SW, Lee SK. Free radicals as triggers of brain
edema formation after stroke. Free Radic Biol Med 2005; 39:
51-70.

18.

Guo C, Tong L, Xi M, Yang H, Dong H, Wen A. Neuroprotective
effect of calycosin on cerebral ischemia and reperfusion injury
in rats. J Ethnopharmacol 2012; 144: 768-774.

7.

Margaill I, Plotkine M, Lerouet D. Antioxidant strategies in the
treatment of stroke. Free Radic Biol Med 2005; 39: 429-443.

19.

Janardhan V, Qureshi AI. Mechanisms of ischemic brain injury.
Curr Cardiol Rep 2004; 6: 117-23.

8.

Yen TL, Hsu CK, Lu WJ, Hsieh CY, Hsiao G, Chou DS, Wu GJ,
Sheu JR. Neuroprotective effects of xanthohumol, a crenelated
flavonoid from hops (Humulus lupulus), in ischemic stroke of
rats. J Agric Food Chem 2012; 60: 1937-1944.

20.

Piantadosi CA, Zhang J. Mitochondrial generation of reactive
oxygen species after brain ischemia in the rat. Stroke 1996; 27:
327-331.

9.

Catarino MD, Alves-Silva JM, Pereira OR, Cardoso SM.
Antioxidant capacities of flavones and benefits in oxidativestress related diseases. Curr Top Med Chem 2015; 15: 105-119.

21.

Christophe M, Nicolas S. Mitochondria: a target for
neuroprotective interventions in cerebral ischemiareperfusion. Curr Pharm Des 2006; 12: 739-757.

10.

Lapidot T, Walker MD, Kanner J. Antioxidant and prooxidant
effects of phenolics on pancreatic beta-cells in vitro. J Agric
Food Chem 2002; 50: 7220-7225.

22.

Xiao LH, Yue HW, Ming GB, Guan HD. Chrysin improves
cognitive deficits and brain damage induced by chronic
cerebral hypoperfusion in rats. Eur J Pharmacol 2012; 680: 4148.

11.

Cho H, Yun CW, Park WK, Kong JY, Kim KS, Park Y, Lee S,
Kim BK. Modulation of the activity of pro-inflammatory
enzymes, COX-2 and iNOS, by chrysin derivatives. Pharmacol
Res 2004; 49: 37-43.

23.

Hollman PC, Feskens EJ, Katan MB. Tea flavonols in
cardiovascular disease and cancer epidemiology. Proc Soc Exp
Biol Med 1999; 220: 198-202.

12.

Fu B, Xue J, Li Z, Shi X, Jiang BH, Fang J. Chrysin inhibits
expression of hypoxia-inducible factor-1 alpha through
reducing hypoxia-inducible factor-1 alpha stability and
inhibiting its protein synthesis. Mol Cancer Ther 2007; 6: 220226.

24.

Sakagami H, Jiang Y, Kusama K, Atsumi T, Ueha T, Toguchi
M, Iwakura I, Satoh K, Fukai T, Nomura T. Induction of
apoptosis by flavones, flavonols (3-hydroxyflavones) and
isoprenoid-substituted flavonoids in human oral tumor cell
lines. Anticancer Res 2000; 20: 271-277.

13.

Sobocanec S, Sverko V, Balog T, Sarić A, Rusak G, Likić S,
Kusić B, Katalinić V, Radić S, Marotti T. Oxidant/antioxidant
properties of Croatian native propolis. J Agric Food Chem
2006; 54: 8018-8026.

25.

Rapta P, Misik V, Stasko A, Vrabel I. Redox intermediates
of ﬂavonoids and caffeic acid esters from propolis: an EPR
spectroscopy and cyclic voltammetry study. Free Radic Biol
Med 1995; 18: 901-908.

14.

Yonekura I, Kawahara N, Nakatomi H, Furuya K, Kirino T. A
model of global cerebral ischemia in C57 BL/6 mice. J Cereb
Blood Flow Metab 2004; 24: 151-158.

26.

Williams CA, Harborne JB, Newman M, Greenham J, Eagles
J. Chrysin and other leaf exudate flavonoids in the genus
Pelargonium. Phytochemistry 1997; 46: 1349-1353.

15.

Ciftci O, Ozdemir I, Vardi N, Beytur A, Oguz F. Ameliorating
effects of quercetin and chrysin on 2,3,7,8-tetrachlorodibenzop-dioxin-induced nephrotoxicity in rats. Toxicol Ind Health
2012; 28: 947-954.

27.

Duarte J, Jiménez R, Villar IC, Pérez-Vizcaíno F, Jiménez J,
Tamargo J. Vasorelaxant effects of the bioflavonoid chrysin in
isolated rat aorta. Planta Med 2001; 67: 567-569.

28.

Wang JJ, Cui P. Neohesperidin attenuates cerebral ischemiareperfusion injury via inhibiting the apoptotic pathway and
activating the Akt/Nrf2/HO-1 pathway. J Asian Nat Prod Res
2013; 15: 1023-1037.

16.

Oguzturk H, Ciftci O, Aydin M, Timurkaan N, Beytur A, Yilmaz
F. Ameliorative effects of curcumin against acute cadmium
toxicity on male reproductive system in rats. Andrologia 2012;
44: 243-249.

1933

